RegMed Investors’ (RMi) closing bell; bowling for strikes, it’s all in the approach

September 21, 2017 6:57pm

Bowling strikes: CLLS, SGMO, RGNX and QURE

As compared to those who can’t keep away the gutter balls: AGTC, BSTG, CAPR, NWBO

Pre-open indications: 3 hits and 2 miss (by pennies0

Are the truths of “our” universe that hard to accept – not here!

I answer one question, in which company should investors commit and keep their money. In the grip of rotating cycles and disparaging trends, what is the price of sector knowledge – a subscription! 

Thursday’s results have implications to Friday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

Henry’omics:

From the pre-open’s newsletter “…there exists a fundamental mistrust … of reporting unpleasant facts, opinions and analysis.  In the factors of warnings … the uneasiness of knowledge and perception reflect timing and judgement.”

The sector’s losses were shallow but broad …

Cell, stem and gene therapy companies moved to the downside again on what – an algorithmic computation.

Some of MY working trend lines or indications:

… The greatest volume to the downside:  CUR, ATHX, CYTX, QURE and BSTG

… Upside volume was weighted to:  MDXG, JUNO, CAPR, KITE and VSTM

… Biggest $ downside:  JUNO, BLUE, ONCE, BLCM and KITE

… Largest $ upside:  QURE, ISCO, FCSC, AXGN and RGNX

… Flat:  RENE.L, PSTI, VCEL, ADRO, STML and AGTC

CAPR is DOWN -$0.03 again following Wednesday’s -$0.22 after Tuesday’s +$0.93 after Monday’s +$0.32 on a press release of October’s data release – wait for the erosion! Icarus flew high and crashed into the sea – just another I told you so as CEO Marban gets MY “rocket women CEO” designation!

Biostage (BSTG) closed up +$0.0027 after Wednesday’s down -0.0057 – another  failed company kept alive by issues of salary continuation; thus James McGorry gets a “rocket man” designation as BSTG contemplates legal “suicide” – a bankruptcy … IF a judge does NOT rule in their favor in the on-going and unresolved terminal death suit!

Applied Genetics  Technologies (AGTC) closed flat at $3.65 after Tuesday’s  -$0.025 following CEO Susan Washer, a recipient of the “rocket women” designation for assisting in the destruction of her companies share pricing and doing NOTHING … to mitigate the issues!

Lighting the stock price on fire was:  QURE, CLLS, STML, ISCO, FCSC, ATHX and RGNX to name a few …

KITE was DOWN with JUNO, BLUE, BLCM and VSTM – the “runners” of past weeks

Mid-tiers getting “whacked” were: HSGX, CLBS, XON, MDXG, AST, FATE, ONVO and BTX to name a few … and never forget – VTGN

Even PSTI was flat at $1.56 after yesterday’s $0.03 – never holds, it will decline … MORE!

BLFS was up +$0.07 with low volume (66.2 K shares) after yesterday’s -$0.13 after Tuesday’s -$0.14 after Monday’s +$0.44 to $5.29 – something is up as volume is huge, 947.8 K shares traded <3 month average = 141.02 K shares> - it better happen soon like an offering to raise cash and not live on debt or are they preparing for a take-out after 12/31/16’s price of $1.61 … or as I stated yesterday, is there a strategy here or will an Icarus flight pattern be readied?

It’s just a merry-go-round of share pricing – get on and when the music changes get off – to get back on when the tune changes …

Pre-open indications: 3 hits and 2 miss:

• bluebird bio (BLUE) closed down -$2.95 – hit;
• Capricor (CAPR) closed down -$0.03 – hit;
• Cellectis SA (CLLS) closed up +$0.03 – miss;
• BioLife Solutions (BLFS) closed up +$0.07 – miss;
• Juno Therapeutics (JUNO) closed down -$3.59 – hit;

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The first hour was negative with an A/DL of 14/27 and 2 flats;

·         The mid-day was negative  with an A/DL of 17/24 and 2 flat;

·         The close was negative with an A/DL of 16/21 and 6 flat;

Daily analytics:

U.S. stocks finished lower Thursday, with the Dow snapping a nine-day winning streak as investors found few reasons to chase equities a day after the Federal Reserve indicated it still intends to deliver another rate increase in 2017 and detailed the unwinding of $4.5 trillion balance sheet.

• The Dow fell 53.36 points, or 0.2%, to close at 22,359.23, though it briefly inched up to a new intraday record at 22,419.51 before retreating.
• The S&P 500 slipped 7.64 points, or 0.3%, to end at 2,500.60.
• The NASDAQ fell 33.35 points, or 0.5%, to close at 6,422.69.

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market; Thursday traded at 9.67, down -1.12% …

• Wednesday traded at 9.78, down -3.93% after Tuesday closed at 10.18, up +0.30% after Monday traded at 10.15, down -0.20% after Friday traded at 10.21, down -2.30% and last Thursday traded at 10.44, down -0.57%

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Thursday was DOWN -0.10%

·         Wednesday +0.33%

·         Tuesday was FLAT (haven’t seen that in quite a while)

·         Monday +0.70%

·         Friday +0.45%

·         Last Thursday -0.08%

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Thursday was DOWN -0.44%

·         Wednesday +0.85%

·         Tuesday -0.67%

·         Monday +0.11%

·         Friday -0.07%

·         Last Thursday -0.59%

The count - decliners versus gainers:

……. look at the differences in the spreads as decliners jump and %

·         Thursday’s decliners ranged from -0.20% <KITE -$0.20 > to -9.36% <OPXA -$0.10 > in 21 equities;

·         Wednesday’s decliners ranged from -0.18% < MESO -$0.01> to -19.63% < NWBO -$0.043> in 23 equities;

·         Tuesday’s decliners ranged from -0.31% <BLCM -$0.04> to -3.73% <MDXG -$0.51> in 21 equities;

·         Monday’s decliners ranged from -0.36% <BSTG -$0.0012> to -6.13% <ONVO -$0.13> in 11 equities;

·         Friday’s decliners ranged from -0.19% <BLUE -$0.25> to -6.19% <ONVO -$0.14> in 19 equities;

·         Last Thursday’s decliners ranged from -1.20% <CYTX -$0.0042> to -4.74% <XON -$0.94> in 22 equities;

Versus

… Look at the percentage’s (%) and spreads …

·         Thursday’s gainers ranged from +0.11% <CLLS +$0.03> to +12.01% <QURE +$1.02> in 16 equities;

·         Wednesday’s gainers ranged from +0.11% <CLLS ++0.03> to +17.83% <CUR +$0.21> in 19 equities;

·         Tuesday’s gainers ranged from +0.26% <CLBS +$0.01> to +70.45% <CAPR +$0.93> in 19 equities;

·         Monday’s gainers ranged from +0.16% <KITE +$0.28> to +32% <CAPR +$0.32> in 28 equities;

·         Friday’s gainers ranged from +0.66% <ONCE +$0.54> to +8.52% <BLCM +$0.92> in 23 equities;

·         Last Thursday’s gainers ranged from +0.21% <BLFS +$0.01> to +4.39% <BLUE +$5.55> in 20 equities;

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.